Adrenal Cortical Carcinoma

This is a type of cancer that starts in the adrenal glands, which are small glands on top of your kidneys. It's a serious condition that needs medical treatment.

Condition

What people with Adrenal Cortical Carcinoma report

Every report comes from a Lived member, sent anonymously.

Have you had Adrenalectomy for Adrenal Cortical Carcinoma?

NameHow it went

About Adrenal Cortical Carcinoma

What It Is

Adrenal cortical carcinoma, also called adrenocortical carcinoma or ACC, is a rare cancer that starts in the outer layer (the cortex) of an adrenal gland. The two adrenal glands sit on top of the kidneys, and the cortex makes hormones the body depends on, including cortisol, which helps regulate blood sugar, blood pressure and the response to stress; aldosterone, which balances salt and water; and sex hormones. Many of these cancers keep making hormones, but in uncontrolled amounts. Too much cortisol can cause Cushing syndrome: weight gain in the face and trunk with thin arms and legs, a round red face, muscle weakness, high blood sugar and high blood pressure. Excess male-type hormones can cause facial hair, acne and loss of periods in women, while excess estrogen can cause breast growth in men. Tumors that make no extra hormone may cause no symptoms until they grow large enough to cause pain or fullness in the abdomen or back. ACC is different from the much more common benign adrenal growths, and from pheochromocytoma, a tumor of the inner part of the gland.

Causes & Risk Factors

In most people, no cause is found. Some inherited conditions raise the risk, most notably Li-Fraumeni syndrome, as well as Beckwith-Wiedemann syndrome and Carney complex. Having one of these does not mean someone will develop ACC, and most people who develop it have no known risk factor. ACC can occur at any age, including in children, but it is mainly a disease of adults. Childhood ACC is treated differently from adult disease, and this page describes ACC in adults.

How It's Diagnosed

Diagnosis usually starts with symptoms of hormone excess or with an adrenal mass seen on a scan, sometimes one done for another reason. Because most adrenal masses are not cancer, the workup aims to answer two questions: is the mass making hormones, and does it look malignant? Blood and urine tests measure cortisol, sex hormones, aldosterone and related substances. These results matter beyond diagnosis: they guide hormone control before surgery, and a hormone the tumor makes can later be tracked as a sign of whether treatment is working. Testing also checks for pheochromocytoma, because a needle biopsy of that tumor can trigger a dangerous spike in blood pressure; a biopsy is considered only after it has been ruled out. Computed tomography (CT) or magnetic resonance imaging (MRI) scans of the abdomen show the size and features of the mass, and a CT of the chest looks for spread to the lungs. A pathologist confirms the diagnosis by examining tumor tissue, often after surgery has removed it, and reports how fast the cells are dividing, which helps predict the risk of the cancer coming back. The stage reflects the size and spread of the tumor: stage I and II tumors are confined to the adrenal gland (5 centimeters or smaller, or larger than 5 centimeters), stage III has spread to nearby lymph nodes, organs or large veins, and stage IV has spread to distant sites such as the lungs, liver or bone.

Treatment Options

Because ACC is rare, guidelines recommend that a team experienced in adrenal cancer plan care, and that surgery be done by a surgeon experienced in adrenal cancer operations. Surgery to remove the tumor and affected gland completely (adrenalectomy) is the main treatment for cancer that has not spread, and it offers the best chance of long-term control. Leaving cancer cells behind makes recurrence more likely, which is why the first operation matters so much. Mitotane (Lysodren) is a pill that damages adrenal cortex cells and lowers their hormone production. After complete surgery, it is suggested for people at higher risk of the cancer returning, such as those with stage III disease, cancer left at the edges of the removed tissue, or fast-dividing tumor cells. A randomized trial found no clear benefit from routine mitotane after surgery for lower-risk disease. Mitotane takes three to five months to reach effective blood levels, needs regular blood tests to adjust the dose, and often causes nausea, loss of appetite, diarrhea and dizziness. It also suppresses the body's own cortisol, so people taking it need steroid replacement (usually hydrocortisone), and infection, injury or other illness can tip them into adrenal crisis, a life-threatening shortage of cortisol. When cancer cannot be completely removed or has spread, treatment aims to control growth and symptoms. Options include mitotane alone for slower, lower-volume disease, or chemotherapy combining etoposide, doxorubicin and cisplatin with mitotane when faster control is needed. In the main trial, this combination shrank tumors in about one in four people and delayed growth by a few months on average, with real side effects. Radiation, ablation that destroys tumors with heat, and surgery for a limited number of spots can help selected people. Hormone-blocking medicines can relieve symptoms of cortisol excess even when the tumor itself is hard to control. Immunotherapy and targeted drugs help some people, but there is no reliable way yet to predict who, and clinical trials are a reasonable option at any stage.

What to Expect

The outlook depends mainly on the stage at diagnosis, whether surgery removed the tumor completely, and how fast the cells are growing. Cancer found early and fully removed may be cured, while cancer that has spread to distant organs is usually not curable, though treatment can control it and relieve symptoms for a time. Even after complete surgery, ACC can come back, so follow-up continues with regular scans and hormone tests after treatment ends. A recurrence that appears after a long disease-free interval can sometimes be treated with surgery or other local treatment again. Daily life is often shaped as much by hormones as by the cancer. People taking mitotane may feel nauseated, dizzy or mentally slowed, and they need frequent blood tests and steroid replacement. Managing that replacement, including knowing when to take extra during illness, becomes a routine skill, and people are advised to carry medical identification that says they have adrenal insufficiency. Living with a rare cancer and a hormone deficiency at the same time can be demanding, and support from family and an experienced care team makes self-care easier.

When to Seek Help

See a clinician if you notice a lump, pain or fullness in the abdomen or back, rapid weight gain in the face and trunk with thinning arms and legs, or, in women, new facial hair, a deepening voice or periods that stop. Many other conditions can cause these, but an assessment can sort them out. If you take mitotane or steroid replacement, contact your care team right away if you develop an infection, have an injury or another illness, or cannot keep your steroid pills down, because you may need extra steroid. Signs of adrenal crisis, such as severe weakness, confusion or fainting, severe vomiting, or severe abdominal pain with dizziness, are an emergency: call 911.

Questions to Ask Your Doctor

  1. 1.What stage is my cancer, and was it completely removed?
  2. 2.How experienced is this team with adrenocortical carcinoma, and should part of my care happen at a specialist center?
  3. 3.Is my risk of recurrence high enough that mitotane after surgery makes sense for me?
  4. 4.Will I need steroid replacement, and what should I do with my dose when I am sick?
  5. 5.Should I or my family have genetic counseling or testing for an inherited condition?

Last reviewed • Oct 2026

Educational content, not medical advice.